✦ LIBER ✦

Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis

✍ Scribed by Passeri, M.; Baroni, M.C.; Pedrazzoni, M.; Pioli, G.; Barbagallo, M.; Costi, D.; Biondi, M.; Girasole, G.; Arlunno, B.; Palummeri, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Paget's disease of bone wit

✍ S. Adami; G. Salvagno; G. Guarrera; F. Montesanti; S. Garavelli; S. Rosini; V. L 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 330 KB

The use of intravenous 3-amino-1-hydroxy

✍ Buckler, H.M.; Cantrill, J.A.; Anderson, D.C. 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 143 KB

One year of treatment with PTH (1–84) an

✍ D. Hosking; M. Brandi; M. Díaz-Curiel; D. Felsenberg; L.H. Hyldstrup 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Serum calcium levels in postmenopausal w

✍ M. Díaz-Curiel; D. Hosking; M. Brandi; L.H. Hyldstrup; D. Felsenberg 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Site-Specific Variation in the Classific

✍ O. Sahota; D. Pearson; S. W. Cawte; P. San; D. J. Hosking 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 114 KB

Carcinogenicity of 2-amino-1-methyl-6-ph

✍ Tomoyuki Shirai; Lin Cui; Satoru Takahashi; Mitsuru Futakuchi; Makoto Asamoto; K 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 339 KB